MedTrace Logo

A Combinatorial Biomarker for Infection Diagnosis in Children

NCT05971901 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 770

Last updated 2023-08-02

No results posted yet for this study

Summary

To describe the epidemiology, clinical presentation, diagnosis, therapy, and treatment outcomes of patients in whom the combination biomarker BV (combination of TRAIL, IP-10, and CRP) is used, and to compare them with control patients without BV measurement.

Secondary objectives:

* Qualitative evaluation of indication as well as adherence to the test result.
* Comparison of antimicrobial therapy, performed diagnostics, hospitalization, and outcomes between patients with high BV score (bacterial) and patients with low BV score (viral).

Conditions

  • Respiratory Tract Infections
  • Fever

Interventions

DIAGNOSTIC_TEST

BV

The use of the BV test, ordered at the discretion of the treating physician

Sponsors & Collaborators

  • Universität des Saarlandes

    lead OTHER

Principal Investigators

  • Cihan Papan, MD · Universität des Saarlandes

Eligibility

Min Age
5 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-24
Primary Completion
2024-10-31
Completion
2024-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05971901 on ClinicalTrials.gov